Zuphil 800mg Tablet contains Piracetam, a nootropic agent belonging to the racetam family, indicated for the treatment of cognitive disorders and neurological conditions associated with impaired memory and learning. Each tablet delivers 800mg of Piracetam, which acts by modulating neurotransmission and enhancing cerebral metabolism, thereby improving neuronal function and synaptic plasticity. Zuphil is commonly prescribed for patients experiencing cognitive decline due to aging, cerebrovascular insufficiency, dementia, or traumatic brain injury. It has also demonstrated efficacy in managing myoclonus and certain types of vertigo. The mechanism of action involves the facilitation of acetylcholine neurotransmission and increased oxygen and glucose utilization in brain tissues, contributing to enhanced mental alertness and memory retention. Zuphil 800mg is administered orally, with dosage tailored according to clinical response and patient tolerance, typically ranging from 1.2 to 4.8 grams daily in divided doses. It is generally well tolerated, with adverse effects such as nervousness, agitation, or gastrointestinal disturbances being infrequent and mild. Caution is advised in patients with renal impairment, and use during pregnancy or lactation should be under medical supervision. Zuphil should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.